Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Rugeles

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Current HIV Research|November 11, 2008
Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individualsWildeman Zapata, Benigno Rodriguez, Jan Weber, et al.
AIDS (London, England)|February 25, 2003
Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognitionMaria T Rugeles, Charles M Trubey, Victoria I Bedoya, et al.
Frontiers in Immunology|March 1, 2017
High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative IndividualsWbeimar Aguilar-Jimenez, Irma Saulle, Daria Trabattoni, et al.
Immunobiology|December 15, 2019
Characterization of CXCR5<sup>+</sup> CD8<sup>+</sup> T-cells in humanized NSG miceFederico Perdomo-Celis, Sandra Medina-Moreno, Harry Davis, et al.
Immunologic Research|January 4, 2016
Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDSSandra M Gonzalez, Natalia A Taborda, Luis A Correa, et al.
Frontiers in Immunology|May 4, 2026
Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expressionSandra M Gonzalez, Wbeimar Aguilar-Jimenez, Maria T Rugeles, et al.
Frontiers in Immunology|May 19, 2022
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six MonthsTulio J Lopera, Mateo Chvatal-Medina, Lizdany Flórez-Álvarez, et al.
Frontiers in Immunology|May 14, 2023
PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication <i>in vitro</i>Damariz Marín-Palma, Jorge H Tabares-Guevara, María I Zapata-Cardona, et al.
Trials|June 23, 2009
Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trialCarlos J Montoya, Fabian Jaimes, Edwin A Higuita, et al.
Biomolecules|March 28, 2025
Vitamin D Decreases Susceptibility of CD4<sup>+</sup> T Cells to HIV Infection by Reducing AKT Phosphorylation and Glucose Uptake: A Bioinformatic and In Vitro ApproachJohn D Loaiza, Jose Fernando Gómez, Daniel Muñoz-Escudero, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Current HIV Research|November 11, 2008
Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individualsWildeman Zapata, Benigno Rodriguez, Jan Weber, et al.
AIDS (London, England)|February 25, 2003
Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognitionMaria T Rugeles, Charles M Trubey, Victoria I Bedoya, et al.
Frontiers in Immunology|March 1, 2017
High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative IndividualsWbeimar Aguilar-Jimenez, Irma Saulle, Daria Trabattoni, et al.
Immunobiology|December 15, 2019
Characterization of CXCR5<sup>+</sup> CD8<sup>+</sup> T-cells in humanized NSG miceFederico Perdomo-Celis, Sandra Medina-Moreno, Harry Davis, et al.
Immunologic Research|January 4, 2016
Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDSSandra M Gonzalez, Natalia A Taborda, Luis A Correa, et al.
Frontiers in Immunology|May 4, 2026
Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expressionSandra M Gonzalez, Wbeimar Aguilar-Jimenez, Maria T Rugeles, et al.
Frontiers in Immunology|May 19, 2022
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six MonthsTulio J Lopera, Mateo Chvatal-Medina, Lizdany Flórez-Álvarez, et al.
Frontiers in Immunology|May 14, 2023
PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication <i>in vitro</i>Damariz Marín-Palma, Jorge H Tabares-Guevara, María I Zapata-Cardona, et al.
Trials|June 23, 2009
Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trialCarlos J Montoya, Fabian Jaimes, Edwin A Higuita, et al.
Biomolecules|March 28, 2025
Vitamin D Decreases Susceptibility of CD4<sup>+</sup> T Cells to HIV Infection by Reducing AKT Phosphorylation and Glucose Uptake: A Bioinformatic and In Vitro ApproachJohn D Loaiza, Jose Fernando Gómez, Daniel Muñoz-Escudero, et al.
Pageof 5